Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Porter

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
The Journal of Allergy and Clinical Immunology|August 11, 2020
Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignanciesCraig W Freyer, David L Porter
Hematology. American Society of Hematology. Education Program|December 4, 2020
Immunotherapy with cellsElise A Chong, David L Porter
American Journal of Hematology|September 19, 2012
A classic presentation of an uncommon leukemiaKara N Maxwell, David L Porter
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Umbilical cord blood transplantation: where do we stand?Raymond C Wadlow, David L Porter
Pharmacotherapy|May 9, 2020
Advances in CAR T Therapy for Hematologic MalignanciesCraig W Freyer, David L Porter
Current Opinion in Oncology|February 8, 2006
Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantationAlison W Loren, David L Porter
Transplantation and Cellular Therapy|May 7, 2025
Profile of a Pioneer: Carl H. JuneDavid L Porter, Stephan A Grupp
Hematology. American Society of Hematology. Education Program|December 4, 2016
Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemiaNoelle V Frey, David L Porter
Best Practice & Research. Clinical Haematology|May 28, 2008
Graft-versus-host disease after donor leukocyte infusions: presentation and managementNoelle V Frey, David L Porter
American Journal of Hematology|March 13, 2019
Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemiaSteven M Bair, David L Porter
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
The Journal of Allergy and Clinical Immunology|August 11, 2020
Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignanciesCraig W Freyer, David L Porter
Hematology. American Society of Hematology. Education Program|December 4, 2020
Immunotherapy with cellsElise A Chong, David L Porter
American Journal of Hematology|September 19, 2012
A classic presentation of an uncommon leukemiaKara N Maxwell, David L Porter
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Umbilical cord blood transplantation: where do we stand?Raymond C Wadlow, David L Porter
Pharmacotherapy|May 9, 2020
Advances in CAR T Therapy for Hematologic MalignanciesCraig W Freyer, David L Porter
Current Opinion in Oncology|February 8, 2006
Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantationAlison W Loren, David L Porter
Transplantation and Cellular Therapy|May 7, 2025
Profile of a Pioneer: Carl H. JuneDavid L Porter, Stephan A Grupp
Hematology. American Society of Hematology. Education Program|December 4, 2016
Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemiaNoelle V Frey, David L Porter
Best Practice & Research. Clinical Haematology|May 28, 2008
Graft-versus-host disease after donor leukocyte infusions: presentation and managementNoelle V Frey, David L Porter
American Journal of Hematology|March 13, 2019
Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemiaSteven M Bair, David L Porter
Pageof 20